Based on these results, we hypothesize that ERRα overexpression could increase in situ steroidogenesis or androgen biosynthesis in prostate cancer cells, leading to increased androgen levels in LNCaP-ERRα-derived tumors under castration condition, which promotes, at least in part, in vivo castration-resistant tumorigenicity. The gene discussed is ESRRA; the disease is prostate cancer.